HOBSCOTCH for Post-COVID Syndrome

N/A

Recruiting

Led By Elaine T Kiriakopoulos, MD, MPH, MSc

Research Sponsored by Dartmouth-Hitchcock Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Literate, English-speaking with grade 12 or equivalent in education

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up after completion of the hobscotch-pacs intervention and all post-hobscotch-pacs assessments, approximately 9 weeks after enrollment.

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to see if a home-based epilepsy self-management program, HOBSCOTCH, can be adapted for people with Post Acute Covid Syndrome (PACS). Participants will attend virtual sessions

Who is the study for?

This trial is for English-speaking individuals with at least a grade 12 education level who have post-acute COVID-19 syndrome (PACS) and self-reported memory or cognitive issues. They must have telephone and internet access to participate in virtual sessions.

What is being tested?

The study tests if the HOBSCOTCH program, originally for epilepsy self-management, can help improve quality of life for people with PACS. It involves nine one-hour online sessions with a coach, questionnaires on health and cognition, daily symptom diaries, and satisfaction surveys.

What are the potential side effects?

Since this intervention is non-medical involving coaching sessions and self-management strategies without drugs or medical procedures, no direct side effects are expected from the HOBSCOTCH-PACS program itself.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I can read and speak English and have completed grade 12 or equivalent.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline (pre-hobscotch-pacs) and post-hobscotch-pacs, approximately 9 weeks later.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline (pre-hobscotch-pacs) and post-hobscotch-pacs, approximately 9 weeks later.

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (pre-hobscotch-pacs) and post-hobscotch-pacs, approximately 9 weeks later. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change in overall quality of life as measured by comparing PROMIS-10 Global Health scores pre- and post-HOBSCOTCH-PACS intervention.

Change in subjective cognition as measured by comparing Neuro-QOL Item Bank v2.0 Cognitive Function scores pre- and post-HOBSCOTCH-PACS intervention.

Secondary study objectives

Change in objective cognition as measured by comparing California Verbal Learning Test-III scores pre- and post-HOBSCOTCH-PACS intervention.

Change in objective cognition as measured by comparing Montreal Cognitive Assessment (MOCA) scores pre- and post-HOBSCOTCH-PACS intervention.

Change in objective cognition as measured by comparing Symbol-Digit Modalities Test scores pre- and post-HOBSCOTCH-PACS intervention.

+11 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: PACS Participant With Cognitive and Memory DysfunctionExperimental Treatment1 Intervention

Participants will receive the HOBSCOTCH-PACS intervention consisting of 1:1 sessions delivered once per week including: 1 pre-HOBSCOTCH Session (on webcam or by phone) 1 educational session (on webcam) 6 HOBSCOTCH intervention sessions (webcam or phone) 1 wrap-up session (webcam or phone)

0 / 1Eligibility criteria met